What the Price Implies

Figures converted from IDR at historical FX rates — see data/company.json.fx_rates (2025-12-31: Rp1 = $0.000060; 2026-07-22: Rp1 = $0.000056). Ratios, margins, and multiples are unitless and unchanged.

What the Price Implies

At $0.076 a share, MSTI trades at 7.7x trailing earnings — but strip out the roughly $92 million of net cash that is about 36% of its market value and the market is paying about 5x earnings for the operating business itself. That price discounts the bear case built through the prior chapters: a mid-single-digit-growth reseller with a narrow moat and idle cash. The cheapness is real, but the founding family controls ~85% of the shares, so whether a minority holder ever captures it depends on decisions only the family can make.

Share Price (US¢)

7.56

Market Cap ($M)

237

Net Cash ($M)

92

Trailing P/E

7.7

EV / Earnings

4.9

Dividend Yield

8.7%

Sources: share price $0.076 (Rp1,350 at 22 Jul 2026, as reported); market cap = 3,139,416,200 shares [1] × price; net cash = $97.6m cash [2] less $6.0m total borrowings [3]; earnings FY2025 net income $32.9m [4]. Balance-sheet and income figures converted at the 2025-12-31 rate; price and market cap at the 2026-07-22 rate.

The cash makes the headline multiple misleading

The 7.7x trailing P/E understates how cheaply the market prices what MSTI actually does. FY2025 net income was $32.9 million [5] on operating profit of $39.8 million [6]; against a $237 million market cap that is 7.7x earnings and 6.4x operating profit. But the company ended 2025 with $97.6 million of cash [7] against only $6.0 million of total borrowings including lease liabilities [8] — net cash of about $92 million ($97 million excluding leases, the basis used in Cash Conversion). That pile is roughly 36% of the market cap, or about $0.027 per share.

Netting it out, enterprise value is about $146 million. After crediting ~$92M of net cash (about 36% of market value), MSTI's operating business trades at only ~4.9x FY2025 earnings and ~4.1x operating profit — but that trailing base is already contracting, with Q1 FY2026 net sales down 8.0% to $65.8M and net profit down 7.5% to $6.4M. A cleaner way to see it: hand the reader the cash at face value, and the residual price for the operating business is what remains.

No Results

Source: derived from FY2025 reported financials — net cash $92m ÷ 3.139bn shares = $0.027/share [9]; operating EPS strips out the after-tax portion of interest income from reported EPS [10]. Per-share operands converted at the 2026-07-22 rate so the multiple reconciles.

So at $0.076 the market values MSTI's core system-integration business at roughly 5x earnings while assigning its cash pile face value. That is a demanding read only if the operating business is worth more than 5x — a business that grew revenue +1.7% in FY2025 [11] and earns an ~18% gross margin no better than peers (Moat and Market). The multiple prices in the reset, not a recovery.

Triangulating against the peers

Three lenses, three answers that broadly agree. On trailing P/E, MSTI's 7.7x sits right on top of Metrodata (MTDL), the largest listed Indonesian IT name, at about 7.7x. On enterprise value MSTI looks cheaper than the headline because so much of its market cap is cash — EV/earnings of ~4.9x against MTDL's ~6.4x EV/EBITDA. And on income, MSTI's 8.7% dividend yield is close to double MTDL's ~4.6%. The one pure-play system-integrator peer, Multipolar (MLPT), is a poor valuation anchor: it carries a reported P/E well above 50x on a thin, controlled float and a dividend yield under 0.5%, so its multiple says more about float scarcity than about what an SI is worth.

No Results

Sources: MSTI trailing P/E and EV/earnings derived from FY2025 financials [12]; dividend $0.0071/share ÷ $0.076 [13]; peer P/E, EV/EBITDA and dividend yields for MTDL and MLPT per current market data (stockanalysis.com / Simply Wall St, as reported). Net income converted at the 2025-12-31 rate.

The peer read cuts both ways. It says MSTI is not obviously mispriced against MTDL on earnings — both trade near 7.7x — but that MSTI carries a materially fatter cash cushion and pays out roughly twice the income. MLPT's ~47% ROE on near-identical ~16% gross margins, noted in Moat and Market, is the reminder that MSTI's own ~24% ROE is depressed by that same idle cash, not evidence of a superior franchise. The market appears to be splitting the difference: crediting the balance sheet with a floor, discounting the operating business for slow growth.

What a range of assumptions implies

A sum-of-the-parts frame shows the answer is most sensitive to the multiple the market assigns the operating business. Credit net cash at ~$0.027 per share and value the ~$31.6 million of operating earnings across a plausible band — 5x (the current implied level), 7x (in line with MTDL), 9x (a re-rating toward the double-digit end-markets management points to).

Loading...

Source: derived from FY2025 reported financials — net cash $0.027/share plus operating net income ~$31.6m valued at 5x/7x/9x ÷ 3.139bn shares [14]. Per-share values converted at the 2026-07-22 rate.

The band runs from about $0.074 (business at 5x) to about $0.112 (business at 9x). The current $0.076 sits at the bottom of that range — the market is paying essentially the bear case. The three-analyst consensus target of $0.099 (a "Strong Buy", range $0.090–0.112, per current sell-side estimates) sits near the middle — but note what it assumes: on FY2026 consensus EPS of $0.0103, $0.099 is 9.6x forward earnings, up from 7.4x today, against EPS growth of only ~5%. The upside the sell-side models is almost entirely a re-rating, not reacceleration. The assumption the whole range is most sensitive to is therefore not next year's earnings — those move little in any case — but whether the market ever assigns the operating business a multiple above the ~5x it pays today, and whether the cash is credited to a minority at all.

The tension, stated as shared facts

The bull and bear here are not arguing about different numbers; they read the same facts in opposite directions. Each row below is a filing item, not a vibe, with the evidence that would settle it.

No Results

Sources: net cash and ROE bridge [15]; FY2025 revenue growth and operating result [16]; dividend and payout [17]; ownership and share count [18].

A measured read

The evidence points one way on the arithmetic and hedges on the outcome. On the numbers, MSTI is cheap: about 5x earnings for the operating business, a $92 million net-cash floor equal to roughly 36% of the market value [19], and an 8.7% dividend paid out of that cash, not borrowed [20]. A holder is paid a high single-digit yield to wait, with a balance sheet that makes permanent loss unlikely.

The strongest fact against that read is that none of the cheapness converts to a minority return on its own. The family owns ~85% and the board carries no independent director, so the two levers that would close the gap — distributing or deploying the $92 million, or reaccelerating growth — are theirs alone to pull, and the low multiple is partly earned by a genuine reset: FY2024's +27.6% leaned on a non-recurring project (Financials and Estimates), and management now guides single-digit growth. What would change the read is concrete and checkable: a capital-return step-up (a larger or repeated interim dividend, a buyout of the float) or a return to double-digit revenue would validate the bull; a second flat year with the cash still idle would confirm that the ~5x is the business, not a discount. This is a value-and-yield holding whose upside is gated on a capital-allocation or growth catalyst the minority cannot compel. The margin of safety is in hand; the catalyst is not.